Ciencias Químicas
Faculty


Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, España
2025
-
SILAC-based nuclear proteomics uncovers antitumor mechanisms of selenium nanoparticles with in vivo validation in a melanoma model
Journal of Drug Delivery Science and Technology, Vol. 111
2024
-
A transmitochondrial sodium gradient controls membrane potential in mammalian mitochondria
Cell, Vol. 187, Núm. 23, pp. 6599-6613.e21
-
Analysis of Vascular Smooth Muscle Cells from Thoracic Aortic Aneurysms Reveals DNA Damage and Cell Cycle Arrest as Hallmarks in Bicuspid Aortic Valve Patients
Journal of Proteome Research, Vol. 23, Núm. 8, pp. 3012-3024
-
Cell response to extracellular matrix viscous energy dissipation outweighs high-rigidity sensing
Science Advances , Vol. 10, Núm. 46
-
Electrogenic and non-electrogenic ion antiporters participate in controling membrane potential
Cell Calcium
-
Exercise and tumor proteome: insights from a neuroblastoma model
Physiological genomics, Vol. 56, Núm. 12, pp. 833-844
-
The Urinary Glycopeptide Profile Differentiates Early Cardiorenal Risk in Subjects Not Meeting Criteria for Chronic Kidney Disease
International Journal of Molecular Sciences, Vol. 25, Núm. 13
2023
-
Cell response to substrate energy dissipation outweighs rigidity sensing
Biophysical journal, Vol. 122, Núm. 3S1
-
Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)
Cell and Bioscience
-
Erythroid SLC7A5/SLC3A2 amino acid carrier controls red blood cell size and maturation
iScience, Vol. 26, Núm. 1
-
Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
Nature Communications, Vol. 14, Núm. 1
-
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Cells, Vol. 12, Núm. 15
-
Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective
Cell and Bioscience, Vol. 13, Núm. 1
2022
-
Electrospraying as a Technique for the Controlled Synthesis of Biocompatible PLGA@Ag2S and PLGA@Ag2S@SPION Nanocarriers with Drug Release Capability
Pharmaceutics, Vol. 14, Núm. 1
-
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
Molecular Therapy - Nucleic Acids, Vol. 28, pp. 124-135
2021
-
Autophagy and the lysosomal system in cancer
Cells, Vol. 10, Núm. 10
-
Cardiovascular Risk Stratification Based on Oxidative Stress for Early Detection of Pathology
Antioxidants and Redox Signaling, Vol. 35, Núm. 8, pp. 602-617
-
Delayed alveolar clearance of nanoparticles through control of coating composition and interaction with lung surfactant protein A
Materials Science and Engineering C
-
Infrared-Emitting Multimodal Nanostructures for Controlled In Vivo Magnetic Hyperthermia
Advanced Materials, Vol. 33, Núm. 30
-
Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson-Gilford Progeria Syndrome
ACS Central Science, Vol. 7, Núm. 8, pp. 1300-1310